TAT 2019 – International Congress on Targeted Anticancer Therapies

The home of phase 1 oncology
TAT 2019 1000x250
Start date
25 Feb 2019
End date
27 Feb 2019
Location
Paris, France

The TAT congress is the premier forum for discussion of early phase drug development and translational research. 

Leaders from academia and industry, clinicians, researchers and regulators work together to speed up the development of new anti-cancer treatments for better patient outcomes.

The TAT Congress series has been at the forefront of revolutionary transformation in early drug development and has succeeded in broadening the conversation on phase I trials to include a wide circle of stakeholders.

TAT 2019 put its participants at the heart of discussions shaping the most promising paths for developing new therapeutics. It provided the opportunity to shape the future of drug development together with the world’s most renowned experts.

We hope to see you at the next edition!

Programme

Programme

Access the online programme for TAT 2019 – Targeted Anticancer Therapies!

Abstracts

Abstracts

TAT 2019 Abstract Book is now available online!

meeting resources

Congress Coverage

Access all the congress resources: slides, presentations, news, press releases and much more.

Congress Officers

Find out who are the TAT 2019 International Congress on Targeted Anticancer Therapies Congress Officers

News & Press

Press & Media

Information for media representatives including press accreditation

Contacts

Contacts

Get in touch with the organisers of TAT 2019 – Targeted Anticancer Therapies. Contact details here

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings